García Pascual Luis, García González Lluís, Lao Luque Xavier, Palomino Meneses Laura, Viscasillas Pallàs Guillem
Servei d'Endocrinologia, Hospital Universitari Mútua de Terrasa, Terrassa, Barcelona, Spain.
Servei de Cirurgia General i Aparell Digestiu, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Endocrinol Diabetes Nutr (Engl Ed). 2023 Mar;70(3):202-211. doi: 10.1016/j.endien.2023.03.012. Epub 2023 Mar 29.
Hypoparathyroidism is the most common complication of total thyroidectomy and usually requires monitoring of calcaemia, whereby it is one of the factors that most contributes to hospital stay. The objective of the study is to evaluate the clinical usefulness of the application of our protocol for early detection, intensive treatment and control of hypoparathyroidism in the first month after thyroidectomy.
Retrospective observational cross-sectional study of 79 patients who underwent total thyroidectomy in whom parathormone (PTH) and calcemia determinations were performed at 6-8 h and 18-24 h post-surgery. When the PTH value was lower than inferior limit of the reference (15 pg/ml), oral treatment was started with 1000 mg of calcium and 0.25 μg of calcitriol every 8 h followed by calcemia controls.
Twenty-six cases (32.9%) of normocalcemic hypoparathyroidism were detected in whom treatment prevented their progression to hypocalcaemia, except for 3 cases that had an episode of mild asymptomatic hypocalcaemia. There were no cases of moderate/severe hypocalcaemia and only one case of asymptomatic mild hypercalcaemia. There were no readmissions due to calcium abnormalities. No case with PTH > 15 pg/ml had hypocalcaemia. The protocol allowed a hospital stay of 24 h. The prevalence of permanent hypoparathyroidism was 5.1%.
The application of our protocol during the first month after thyroidectomy is very useful because it avoids the appearance of moderate/severe hypocalcaemia and hypercalcaemia, allows a short hospital stay and is associated with a low prevalence of permanent hypoparathyroidism.
甲状旁腺功能减退是全甲状腺切除术后最常见的并发症,通常需要监测血钙水平,这是导致住院时间延长的主要因素之一。本研究的目的是评估我们的方案在甲状腺切除术后第一个月早期检测、强化治疗和控制甲状旁腺功能减退的临床实用性。
对79例行全甲状腺切除术的患者进行回顾性观察性横断面研究,在术后6 - 8小时和18 - 24小时测定甲状旁腺激素(PTH)和血钙水平。当PTH值低于参考下限(15 pg/ml)时,开始口服治疗,每8小时服用1000 mg钙和0.25 μg骨化三醇,随后进行血钙水平监测。
检测到26例(32.9%)血钙正常的甲状旁腺功能减退患者,除3例出现轻度无症状性低钙血症外,治疗防止了其进展为低钙血症。没有中度/重度低钙血症病例,仅有1例无症状性轻度高钙血症病例。没有因钙异常再次入院的情况。PTH>15 pg/ml的患者均无低钙血症。该方案使住院时间为24小时。永久性甲状旁腺功能减退的患病率为5.1%。
在甲状腺切除术后第一个月应用我们的方案非常有用,因为它避免了中度/重度低钙血症和高钙血症的出现,缩短了住院时间,且永久性甲状旁腺功能减退的患病率较低。